ANDAs: Impurities in Drug Products: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 29, 2010
April 22, 2020
1729c807-7b92-415c-a307-05a491b55e63
Related Documents
Abuse-Deterrent Opioids-Evaluation and Labeling
Guidance DocumentApril 2, 2015Center for Drug Evaluation and Research
ANDAs: Impurities in Drug Substances: Guidance for Industry
Guidance DocumentJuly 15, 2009Center for Drug Evaluation and Research
ANDAs: Stability Testing of Drug Substances and Products
Guidance DocumentJune 20, 2013Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.